Web-based references relating to the number under the disk sign, listed by page header
Irritable bowel syndrome; Carcinoma of the pancreas
140 The official website
for the Rome II criteria.
[Link]
; page 268
141 Magnetic resonance cholangiopancreatography: image
quality, ductal morphology, and value of additional T2- and T1-weighted
sequences for the assessment of suspected pancreatic cancer. Author: H"inen
EL, Ricke J, Amthauer H, R"ttgen R, B"hmig M, Langrehr J, Pech M, Denecke T,
Rosewicz S, Felix R. Journal: Acta Radiol; 2005 Apr ; 46(2):117-25. PubMed ID:
15902884.
[Link]
; page 268
(footnote) The
roles of endoscopic ultrasonography in the diagnosis of pancreatic tumors.
Author: Maguchi H. Journal: J Hepatobiliary Pancreat Surg; 2004 ; 11(1):1-3.
PubMed ID: 15747027.
[Link]; page 268
142 Giardia lamblia infections become clinically
evident by eliciting symptoms of irritable bowel syndrome. Author: D'Anchino M,
Orlando D, De Feudis L. Journal: J Infect; 2002 Oct ; 45(3):169-72. PubMed ID:
12387773.
[Link]
; page 269
143 Bulking agents, antispasmodic and
antidepressant medication for the treatment of irritable bowel syndrome. Author:
Quartero AO, Meineche-Schmidt V, Muris J, Rubin G, de Wit N. Journal: Cochrane
Database Syst Rev; 2005 ; (2):CD003460. PubMed ID: 15846668.
[Link]
; page 269
144 No link available; page 269
145 Alosetron
1mg/12h PO; page
[Link]
; page 269
146 Efficacy of alosetron in irritable bowel
syndrome: a meta-analysis of randomized controlled trials. Author: Cremonini F,
Delgado-Aros S, Camilleri M. Journal: Neurogastroenterol Motil; 2003 Feb ;
15(1):79-86. PubMed ID: 12588472.
[Link]
; page 269
(footnote) Gut-focused
hypnotherapy normalizes disordered rectal sensitivity in patients with irritable
bowel syndrome. Author: Lea R, Houghton LA, Calvert EL, Larder S, Gonsalkorale
WM, Whelan V, Randles J, Cooper P, Cruickshanks P, Miller V, Whorwell PJ.
Journal: Aliment Pharmacol Ther; 2003 Mar 1 ; 17(5):635-42. PubMed ID: 12641511.
[Link]; page 269
Nutritional disorders
147 Int J Dermatol 1998 Aug;37(8):599
The; page 270
Carcinoid tumours
148 Carcinoid tumour. Author: McStay MK, Caplin ME. Journal:
Minerva Med; 2002 Oct ; 93(5):389-401. PubMed ID: 12410171.
[Link]
; page 270
149 Neuropsychological investigation into the
carcinoid syndrome. Author: Russo S, Nielen MM, Boon JC, Kema IP, Willemse PH,
de Vries EG, Korf J, den Boer JA. Journal: Psychopharmacology (Berl); 2003 Jul ;
168(3):324-8. PubMed ID: 12695876.
[Link]
; page 270
150; page Interest of Chromogranin A for
diagnosis and follow-up of endocrine tumours. Author: Nehar D, Lombard-Bohas C,
Olivieri S, Claustrat B, Chayvialle JA, Penes MC, Sassolas G, Borson-Chazot F.
Journal: Clin Endocrinol (Oxf); 2004 May ; 60(5):644-52. PubMed ID: 15104570.
[Link]
; page 270
151 Current diagnosis and treatment of
gastrointestinal carcinoids in a series of 101 patients: the significance of
serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin
analogues. Author: Nikou GC, Lygidakis NJ, Toubanakis C, Pavlatos S,
Tseleni-Balafouta S, Giannatou E, Mallas E, Safioleas M. Journal:
Hepatogastroenterology; 2005 May-Jun ; 52(63):731-41. PubMed ID: 15966194.
[Link]
; page 270
152 A study of cyproheptadine in the treatment of
metastatic carcinoid tumor and the malignant carcinoid syndrome. Author: Moertel
CG, Kvols LK, Rubin J. Journal: Cancer; 1991 Jan 1 ; 67(1):33-6. PubMed ID:
1985720.
[Link]
; page 270
153 Combination therapy with octreotide and
alpha-interferon: effect on tumor growth in metastatic endocrine
gastroenteropancreatic tumors. Author: Frank M, Klose KJ, Wied M, Ishaque N,
Schade-Brittinger C, Arnold R. Journal: Am J Gastroenterol; 1999 May ;
94(5):1381-7. PubMed ID: 10235222.
[Link]
; page 270
154 Carcinoid tumour. Author: McStay MK, Caplin
ME. Journal: Minerva Med; 2002 Oct ; 93(5):389-401. PubMed ID: 12410171.
[Link]
; page 270
(footnote) James
Lind and Scurvy: a Revaluation
[Link]; page 270
155 A case of biliary carcinoid presenting with
pancreatitis and obstructive jaundice. Author: Juturi JV, Maghfoor I, Doll DC,
Evans ML. Journal: Am J Gastroenterol; 2000 Oct ; 95(10):2973-4. PubMed ID:
11051379.
[Link]
; page 271
Gastrointestinal malabsorption
156 Tropical sprue after travel to Tanzania.
Author: Peetermans WE, Vonck A. Journal: J Travel Med; 2000 Jan ; 7(1):33-4.
PubMed ID: 10689238.
[Link]
; page 272
157 No link available; page 272
Coeliac disease
158 Effect of
an oats-containing gluten-free diet on symptoms and quality of life in coeliac
disease. A randomized study. Author: Per"o M, Kaukinen K, Mustalahti K,
Vuolteenaho N, M" M, Laippala P, Collin P. Journal: Scand J Gastroenterol;
2004 Jan ; 39(1):27-31. PubMed ID: 14992558.
[Link]
; page 272
Chronic pancreatis
159 Exocrine pancreatic insufficiency: accuracy
and clinical value of the uniformly labelled 13C-Hiolein breath test. Author:
Lembcke B, Braden B, Caspary WF. Journal: Gut; 1996 Nov ; 39(5):668-74. PubMed
ID: 9026480.
[Link]
; page 272
Alcoholism
160 The value of the CAGE in screening for
alcohol abuse and alcohol dependence in general clinical populations: a
diagnostic meta-analysis. Author: Aertgeerts B, Buntinx F, Kester A. Journal: J
Clin Epidemiol; 2004 Jan ; 57(1):30-9. PubMed ID: 15019008.
[Link]
; page 274
161 No link available; page 274
162
Attributable risk of injury associated with alcohol use: cross-national data
from the emergency room collaborative alcohol analysis project. Author:
Cherpitel CJ, Ye Y, Bond J. Journal: Am J Public Health; 2005 Feb ;
95(2):266-72. PubMed ID: 15671463.
[Link]
; page 274
163 Acamprosate appears to decrease alcohol
intake in weaned alcoholics. Author: Lhuintre JP, Moore N, Tran G, Steru L,
Langrenon S, Daoust M, Parot P, Ladure P, Libert C, Boismare F. Journal: Alcohol
Alcohol; 1990 ; 25(6):613-22. PubMed ID: 2085344.
[Link]
; page 274
164 No link available; page 274
165 For more
information on alcohol screening tests see:
[Link]
; page 275
166 Brief screening instruments for alcoholism.
Cherpitel CJ. Alcohol Health Res World; 1997 ; 21(4):348-51. PubMed ID: 15706747
[Link]
; page 275
